Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Genvoya®

Editor's pick
Gilead press release
23 November 2015
New & experimental HIV treatments

Genvoya added to US recommended first-line options for HIV treatment

Editor's pick
AIDSinfo
23 November 2015
New & experimental HIV treatments

FDA approves new treatment for HIV

Editor's pick
FDA press release
6 November 2015
Injectable & long-acting HIV treatment

Long-acting injectable HIV treatment shows promise in early study results

Editor's pick
Science Speaks
4 November 2015
New & experimental HIV treatments

ViiV Healthcare announces positive headline results from a study of two drug injectable regimen for HIV maintenance therapy

Editor's pick
ViiV Healthcare
3 November 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial

News
28 October 2015
New & experimental HIV treatments

Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety

News
25 October 2015
Treatment simplification strategies

Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?

News
23 October 2015
New & experimental HIV treatments

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

News
19 October 2015
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

News
14 October 2015
Side effects

TAF and TDF Compared for Kidney, Bone Toxicity in Black HIV+ Patients

Editor's pick
Monthly Prescribing Reference
12 October 2015
HIV treatment

New antiretrovirals and HIV treatment strategies highlighted at ICAAC

News
7 October 2015
Pharmaceutical industry

European CHMP adopts positive opinion for Gilead’s single tablet regimen Genvoya® (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) for the treatment of HIV

Editor's pick
EATG
1 October 2015
Changing treatment

New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq® Maintains HIV Viral Suppression

Editor's pick
Viiv Healthcare press release
23 September 2015
New & experimental HIV treatments

HIV Patients Successfully Reach One Year of Virologic Suppression in PRO 140 Monotherapy Study

Editor's pick
Cytodyn press release
22 September 2015
New & experimental HIV treatments

Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS

Editor's pick
Sangamo press release
22 September 2015
New & experimental HIV treatments

Five Promising HIV Drugs in the Pipeline

Editor's pick
The Body Pro
21 September 2015
Pharmaceutical industry

Fair Pricing Coalition Sign-on Letter to Gilead on Pricing of TAF

Editor's pick
TAG
10 September 2015
New & experimental HIV treatments

Tenofovir Alafenamide Combo Pill Matches Truvada for HIV Efficacy, but Easier on Bones and Kidneys

Editor's pick
HIVandHepatitis.com
4 September 2015
Adherence

The Silent Struggle of HIV Treatment Adherence

Editor's pick
The Body
28 August 2015
Pharmaceutical industry

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Editor's pick
Gilead press release
21 August 2015
New & experimental HIV treatments

'Tweezer' molecule can block HIV in semen, study says

Editor's pick
RT.com
19 August 2015
Access to healthcare

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

Editor's pick
Intellectual Property Watch
4 August 2015
Pharmaceutical industry

GSK flags up pipeline as HIV drugs help it beat profit forecasts

Editor's pick
Reuters
30 July 2015